Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BST/08HH stock hub

BST/08HH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/08HHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.6B

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/08HH

In the news

Latest news · BST/08HH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E17.4

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/08HH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

CNY

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	DE
Employees	40,603
Employees Change	46%
Employees Change Percent	0.11
Enterprise value	EUR 12.5B
Exchange	Stuttgart Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 7.6B
Price	EUR 2.01
Price currency	EUR
Rev Per Employee	131,043.4x
Sic	2834
Symbol	bst/08HH
Website	https://www.fosunpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.73%
EV Earnings	28.52x
EV/EBIT	33.76x
EV/EBITDA	15.25x
EV/FCF	112.06x
EV/Sales	2.36x
FCF yield	1.46%
P/B ratio	0.95x
P/E ratio	17.45x
P/S ratio	1.43x
PE Ratio10 Y	24.88x
PE Ratio3 Y	22.9x
PE Ratio5 Y	24.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.99%
EBITDA Margin	14.6%
FCF margin	2.09%
Gross margin	50.31%
Gross Profit	EUR 2.7B
Gross Profit Growth	11.69%
Gross Profit Growth Q	11.25%
Gross Profit Growth3 Y	-0.71%
Gross Profit Growth5 Y	4.07%
Net Income	EUR 437.2M
Net Income Growth	18.86%
Net Income Growth Q	13.87%
Net Income Growth3 Y	-6.56%
Net Income Growth5 Y	-2.44%
Pretax Margin	12.1%
Profit Margin	8.22%
Profit Per Employee	EUR 10,767
ROA	1.53
Roa5y	1.53
ROCE	3.42
ROE	7.04
Roe5y	7.3
ROIC	2.96
Roic5y	3.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.63%
Cagr1y	11.94%
Cagr3y	-7.1%
Cagr5y	-16.77%
Div CAGR10	-1.26%
Div CAGR3	-10.78%
Div CAGR5	-7.67%
EPS Growth	19.43
EPS Growth Q	13.79
EPS Growth3 Y	-6.71
EPS Growth5 Y	-3.01
FCF Growth	159.5%
OCF Growth	14.97%
OCF Growth Q	8.8%
OCF Growth10 Y	11.28%
OCF Growth3 Y	7.8%
OCF Growth5 Y	12.58%
Revenue Growth	4.92x
Revenue Growth Q	6.93x
Revenue Growth3 Y	-1.62x
Revenue Growth5 Y	5.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.35
Assets	EUR 15.5B
Cash	EUR 1.9B
Current Assets	EUR 4.2B
Current Liabilities	EUR 4.6B
Debt	EUR 5B
Debt EBITDA	EUR 6.04
Debt Equity	EUR 0.62
Debt FCF	EUR 44.67
Equity	EUR 8B
Interest Coverage	2.4
Liabilities	EUR 7.5B
Long Term Assets	EUR 11.2B
Long Term Liabilities	EUR 2.9B
Net Cash	EUR -3B
Net Cash By Market Cap	EUR -39.96
Net Debt EBITDA	EUR 3.92
Net Debt Equity	EUR 0.38
Net Debt FCF	EUR 27.39
Tangible Book Value	EUR 3B
Tangible Book Value Per Share	EUR 1.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.93
Inventory Turnover	3.27
Net Working Capital	EUR 769.4M
Quick ratio	0.71
Working Capital	EUR -328.9M
Working Capital Turnover	EUR -2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.76%
Dividend Growth	7.35%
Dividend Growth Years	1%
Dividend per share	EUR 0.04
Dividend Years	12
Dividend Yield	1.83%
Ex Div Date	2025-07-24
Last Dividend	EUR 0.04
Payout Frequency	Annual
Payout Ratio	62.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	6.47%
1Y total return	11.93%
200-day SMA	2.08
3Y total return	-19.82%
50-day SMA	2.09
50-day SMA vs 200-day SMA	50over200
5Y total return	-60.05%
All Time High	8.68
All Time High Change	-76.8%
All Time High Date	2021-08-04
All Time Low	1.33
All Time Low Change	51.13%
All Time Low Date	2024-09-16
ATR	0.04
Ch YTD	-3.68
High	2.04
High52	3.04
High52 Date	2025-09-12
High52ch	-33.83%
Low	2
Low52	1.81
Low52 Date	2025-06-16
Low52ch	11.46%
Ma50ch	-3.73%
Price vs 200-day SMA	-3.03%
RSI	40.18
RSI Monthly	47.23
RSI Weekly	42.02
Sharpe ratio	0.03x
Sortino ratio	0.13
Total Return	2.58%
Tr YTD	-3.68
Tr1m	-10.45%
Tr1w	0.15%
Tr3m	-6.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 371.8M
Operating Income Growth	11.95
Operating Income Growth Q	25.74
Operating Income Growth3 Y	-6.87
Operating Income Growth5 Y	0.51
Operating margin	6.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,635,575,347%
Net Borrowing	107,024,503.8
Shares Insiders	0.59%
Shares Institutions	15.85%
Shares Qo Q	0.84%
Shares Yo Y	-0.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 85.2M
Average Volume	0x
Bv Per Share	2.34
CAPEX	EUR -555.9M
Ch10y	-10.13
Ch1m	-10.45
Ch1w	0.15
Ch1y	9.76
Ch3m	-6.2
Ch3y	-24.92
Ch5y	-63.68
Ch6m	-26.16
Change	0.9%
Change From Open	0.5
Close	2
Days Gap	0.4
Depreciation Amortization	401,625,402.8
Earnings Date	2026-04-28
EBIT	EUR 371.8M
EBITDA	EUR 776.8M
EPS	EUR 0.16
F Score	6
FCF	EUR 111.3M
FCF EV Yield	0.89x
Financing CF	-167,523,297
Fiscal Year End	December
Founded	1,994
Goodwill	1,346,201,531.3
Graham Number	2.34215
Graham Upside	16.35
Income Tax	EUR 92.5M
Investing CF	-463,986,691
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	EUR 0.58
Lynch Upside	-71.34
Ma150	2.15
Ma150ch	-6.46%
Ma20	2.09
Ma20ch	-3.82%
Net CF	-7,591,769
Next Earnings Date	2026-08-26
Open	2
P FCF Ratio	68.54
P OCF Ratio	11.43
Payment Date	2025-08-22
Position In Range	27.91
Ppne	3,028,667,697.2
Price Date	2026-05-08
Price EBITDA	EUR 9.82
Ptbv Ratio	2.5
Revenue	5,320,755,301x
SBC By Revenue	0.49x
Share Based Comp	26,059,612
Tax By Revenue	1.74x
Tax Rate	14.37%
Tr6m	-26.16%
Z Score	1.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BST/08HH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.04 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.7%

1 consecutive years of growth

Total shareholder yield

+2.6%

Next ex-dividend date: 2025-07-24

Performance

BST/08HH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BST/08HH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.9%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

BST/08HH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

-3.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/08HH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/08HH stock rating?

bst/08HH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/08HH analysis?

The full report lives at /stocks/bst/08HH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/08HH?

The latest report frames bst/08HH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/08HH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.